SCHEMBL5862789

SCHEMBL5862789

O=C(O)c1cc(-c2ccc(C(F)(F)F)cc2)cs1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALAD P13716 2/20 0.63
HDAC6 Q9UBN7 1/20 0.55
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
RXRG P48443 1/20 0.47
KIF11 P52732 5/20 0.46
SLC6A2 P23975 1/20 0.44
P2RY14 Q15391 1/20 0.44
DHODH Q02127 1/20 0.43
SRD5A2 P31213 1/20 0.43
ULK1 O75385 1/20 0.43
DAO P14920 2/20 0.42
MAP4K4 O95819 1/20 0.42
KDM1A O60341 1/20 0.42
CYP2C8 P10632 1/20 0.41
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219141 0.85 HDAC6 (0.50) ALADHDAC6RXRARXRBRXRG
SCHEMBL6875215 0.83 ALAD (0.63) ALADHDAC6RXRARXRBRXRG
SCHEMBL27773427 0.81 HDAC6 (0.47) ALADHDAC6KIF11ULK1PSEN1
SCHEMBL3625585 0.81 ALAD (0.69) ALADHDAC6ULK1DAOMMP12
SCHEMBL6143622 0.81 ALAD (0.69) ALADHDAC6DHODHDAOMMP12
SCHEMBL6374857 0.80 MMP12 (0.61) ALADHDAC6MMP12MMP13
SCHEMBL5861808 0.79 ULK1 (0.46) ALADHDAC6KIF11P2RY14ULK1
SCHEMBL6450949 0.79 ALAD (0.71) ALADHDAC6DAOMMP12MMP13
SCHEMBL4381926 0.79 ALAD (0.66) ALADHDAC6DHODHDAOMMP12
SCHEMBL25552244 0.78 DAO (0.50) ALADHDAC6RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091237-B2 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION (US) 2006-08-15 US disclosed
EP-1392674-B1 FURAN AND THIOPHENE DERIVATIVES THAT ACTIVATE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS SMITHKLINE BEECHAM CORP (US) 2005-08-10 EP disclosed
US-20040157890-A1 Furan and thiophene derivatives that activate human peroxisome profilerator activated receptors GLAXO GROUP LIMITED (GB) 2004-08-12 US disclosed
CN-1507442-A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors 2004-06-23 CN disclosed
EP-1392674-A1 FURAN AND THIOPHENE DERIVATIVES THAT ACTIVATE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS GLAXO GROUP LIMITED (GB) 2004-03-03 EP disclosed
WO-2002092590-A1 FURAN AND THIOPHENE DERIVATIVES THAT ACTIVATE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS GLAXO GROUP LIMITED (GB) 2002-11-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157890-A1 Furan and thiophene derivatives that activate human peroxisome profilerator activated receptors PPARG, PPARD, PPARA ALAD 2672/4885HDAC6 1897/4885RXRA 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.